Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | 16 | 0 | 3 | 0 | €98.38 | €116.81 | 18.731% |
| AbbVie Inc. | 21 | 0 | 4 | 0 | €152.18 | €174.43 | 14.623% |
| Abeona Therapeutics Inc. | 3 | 1 | 1 | 0 | €4.28 | €34.41 | 704.033% |
| AC Immune Ltd | 4 | 0 | 0 | 0 | €2.21 | €12.27 | 455.367% |
| Aclaris Therapeutics Inc | 1 | 0 | 1 | 0 | €1.26 | €3.00 | 138.284% |
| Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €8.28 | €8.50 | 2.719% |
| Adaptimmune Therapeutics PLC ADR | 2 | 0 | 2 | 0 | €1.12 | €1.70 | 51.786% |
| Adverum Biotechnologies Inc. | 6 | 1 | 2 | 0 | €1.38 | €4.66 | 237.768% |
| Affimed N.V. | 8 | 6 | 0 | 0 | €0.55 | €6.54 | 1083.165% |
| Agios Pharmaceuticals Inc. | 5 | 0 | 2 | 0 | €30.60 | €38.99 | 27.414% |
| Akebia Therapeutics Inc. | 8 | 3 | 1 | 0 | €1.28 | €3.60 | 181.840% |
| Akero Therapeutics Inc | 12 | 0 | 0 | 0 | €18.26 | €38.19 | 109.223% |
| Aldeyra Therapeutics Inc. | 2 | 0 | 0 | 0 | €3.87 | - | - |
| Alnylam Pharmace. | 36 | 0 | 3 | 0 | €141.60 | €228.30 | 61.229% |
| Amgen Inc. | 23 | 0 | 4 | 0 | €289.20 | €298.90 | 3.353% |
| Amneal Pharmaceuticals Inc | 1 | 1 | 1 | 0 | €5.80 | €10.00 | 72.414% |
| AnaptysBio Inc | 8 | 1 | 3 | 0 | €24.80 | €46.24 | 86.452% |
| Anika Therapeutics | 4 | 0 | 0 | 0 | €24.60 | €26.58 | 8.054% |
| Apellis Pharmaceuticals | 4 | 0 | 0 | 0 | €44.27 | €70.00 | 58.121% |
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €8.08 | €11.00 | 36.172% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €128.00 | €150.00 | 17.188% |
| AstraZeneca plc | 1 | 0 | 0 | 0 | €141.15 | €165.00 | 16.897% |
| aTyr Pharma Inc | 2 | 0 | 1 | 0 | €1.44 | €10.00 | 594.444% |
| Avadel Pharmaceuticals plc ADR | 1 | 0 | 0 | 0 | €15.10 | €23.00 | 52.318% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |